Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Unterluggauer Julia Judith |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2020

Originalarbeiten (Zeitschrift)

** Roetzer, T; Furtner, J; Gesperger, J; Seebrecht, L; Bandke, D; Brada, M; Brandner-Kokalj, T; Grams, A; Haybaeck, J; Kitzwoegerer, M; Leber, SL; Marhold, F; Moser, P; Sherif, C; Trenkler, J; Unterluggauer, J; Weis, S; Wuertz, F; Hainfellner, JA; Langs, G; Nenning, KH; Woehrer, A Sex-Specific Differences in Primary CNS Lymphoma.
Cancers (Basel). 2020; 12(6): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Korrekturen

** Golob-Schwarzl, N; Bettermann, K; Mehta, AK; Kessler, SM; Unterluggauer, J; Krassnig, S; Kojima, K; Chen, X; Hoshida, Y; Bardeesy, NM; Muller, H; Svendova, V; Schimek, MG; Diwoky, C; Lipfert, A; Mahajan, V; Stumptner, C; Thuringer, A; Frohlich, LF; Stojakovic, T; Nilsson, KPR; Kolbe, T; Rulicke, T; Magin, TM; Strnad, P; Kiemer, AK; Moriggl, R; Haybaeck, J High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype12 (vol 12, pg 256, 2019)
TRANSL ONCOL. 2020; 13(2): 490-492. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2019

Originalarbeiten (Zeitschrift)

** Golob-Schwarzl, N; Bettermann, K; Mehta, AK; Kessler, SM; Unterluggauer, J; Krassnig, S; Kojima, K; Chen, X; Hoshida, Y; Bardeesy, NM; Müller, H; Svendova, V; Schimek, MG; Diwoky, C; Lipfert, A; Mahajan, V; Stumptner, C; Thüringer, A; Fröhlich, LF; Stojakovic, T; Nilsson, KPR; Kolbe, T; Rülicke, T; Magin, TM; Strnad, P; Kiemer, AK; Moriggl, R; Haybaeck, J High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype.
Transl Oncol. 2019; 12(2):256-268 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Neuhauser, M; Roetzer, T; Oberndorfer, S; Kitzwoegerer, M; Payer, F; Unterluggauer, JJ; Haybaeck, J; Stockhammer, G; Iglseder, S; Moser, P; Thomé, C; Stultschnig, M; Wuertz, F; Brandner-Kokalj, T; Weis, S; Bandke, D; Pichler, J; Hutterer, M; Krenosz, KJ; Boehm, A; Mayrbaeurl, B; Hager-Seifert, A; Kaufmann, H; Dumser, M; Reiner-Concin, A; Hoenigschnabl, S; Kleindienst, W; Hoffermann, M; Dieckmann, K; Kiesel, B; Widhalm, G; Marosi, C; Jaeger, U; Hainfellner, A; Hackl, M; Hainfellner, JA; Preusser, M; Woehrer, A Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study.
Acta Oncol. 2019; 49(11):1-10
Web of Science PubMed FullText FullText_MUG

 

** Rössler, I; Embacher, J; Pillet, B; Murat, G; Liesinger, L; Hafner, J; Unterluggauer, JJ; Birner-Gruenberger, R; Kressler, D; Pertschy, B Tsr4 and Nap1, two novel members of the ribosomal protein chaperOME.
Nucleic Acids Res. 2019; 47(13):6984-7002 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2018

Originalarbeiten (Zeitschrift)

** Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Steinbauer, E; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, HT; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, AJA Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favourable cancer specific survival.
Sci Rep. 2018; 8(1):14528-14528 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Qiu, X; Xu, JY; Guo, JJ; Yahia-Ammar, A; Kapetanakis, NI; Duroux-Richard, I; Unterluggauer, JJ; Golob-Schwarzl, N; Regeard, C; Uzan, C; Gouy, S; Dubow, M; Haybaeck, J; Apparailly, F; Busson, P; Hildebrandt, N Advanced microRNA-based cancer diagnostics using amplified time-gated FRET
CHEM SCI. 2018; 9(42): 8046-8055. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kurzbericht/Letter

** Unterluggauer, JJ; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Feichtinger, J; Pichler, M; Weniger, MA; Küppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, AJA; Haybaeck, J Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome.
Blood Cancer J. 2018; 8(9): 79-79. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstracts (Zeitschrift)

** Deutsch, A; Bergmann, TC; Fechter, K; Prochazka, K; Weniger, MA; Kuppers, R; Unterluggauer, JJ; Greinix, H; Beham-Schmid, C; Neumeister, P Low NR4A1 expression is associated with an up-regulation of immune checkpoints and their ligands in DLBCL
ONCOL RES TREAT. 2018; 41: 82-82. [Poster]
Web of Science

 

** Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, A Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favorable cancer specific survival
ONCOL RES TREAT. 2018; 41: 82-83. [Poster]
Web of Science

 

** Pansy, K; Fechter, K; Unterluggauer, JJ; Weniger, MA; Kuppers, R; Greinix, H; Prochazka, K; Karbiener, M; Neumeister, P; Deutsch, A Reduced NR4A1 levels are associated with high expression of miR-15a and miR-15a*in DLBCL
ONCOL RES TREAT. 2018; 41: 81-81. [Poster]
Web of Science

 

** Schukoff, T; Winkler, S; Unterluggauer, JJ; Fechter, K; Greinix, H; Beham-Schmid, C; Schaider, H; Deutsch, A; Prochazka, K; Neumeister, P Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphoma
ONCOL RES TREAT. 2018; 41: 50-50. [Poster]
Web of Science

 

** Unterluggauer, JJ; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Feichtinger, J; Pichler, M; Weniger, MA; Kuppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, A; Haybaeck, J Translation initiation factors are over-expressed in aggressive lymphomas and influence their clinical course
ONCOL RES TREAT. 2018; 41: 164-164. [Poster]
Web of Science

 

© Med Uni Graz Impressum